-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATH-1020 in Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-1020 in Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-1020 in Depression Drug Details: ATH-1020 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATH-1020 in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-1020 in Schizophrenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-1020 in Schizophrenia Drug Details: ATH-1020 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATH-399A in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-399A in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-399A in Parkinson's Disease Drug Details: ATH-399A is under investigation for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATH-1020 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-1020 in Neurodegenerative Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-1020 in Neurodegenerative Diseases Drug Details: ATH-1020 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATH-1020 in Anxiety Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-1020 in Anxiety Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-1020 in Anxiety Disorders Drug Details: ATH-1020 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ATH-1020 in Neuropathic Pain (Neuralgia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-1020 in Neuropathic Pain (Neuralgia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-1020 in Neuropathic Pain (Neuralgia) Drug Details: ATH-1020 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vemurafenib in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vemurafenib in Neuroblastoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vemurafenib in Neuroblastoma Drug Details: Vemurafenib (Zelboraf, RG7204, PLX4032, RO5185426) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMC-002 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMC-002 in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMC-002 in Metastatic Ovarian Cancer Drug Details: IMC-002 is under investigation...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Diffuse Large B-Cell Lymphoma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-426 in Zika Virus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TAK-426 in Zika Virus InfectionsDrug Details:TAK-426 is under development for the prevention of Zika virus infections....